Emelie Heintz

Emelie Heintz

Adjunct Lecturer | Docent
Visiting address: Tomtebodavägen 18A, 17165 Solna
Postal address: C7 Lärande, Informatik, Management och Etik, C7 Hälsoekonomi och Policy Rehnberg, 171 77 Stockholm
Part of:

About me

  • I am working as head of Stockholm Centre for Health Economics (StoCHE) at Region Stockholm and an adjunct Associate professor at LIME at KI.

    I have previously worked as a health economist and coordinator for health economics at the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) and as a project manager for a research program focusing on patient-reported outcome measures (PROMs) at QRC Stockholm.

    More information about StocHE is available at: https://www.chis.regionstockholm.se/StoCHE/

Research

  • My research focuses on health economic evaluations of health care interventions as well as the assessment and use of patient-reported outcome measures (PROMs) to measure and value health and health-related quality of life (HRQoL). 

    As part of my research at LIME, I am involved in projects related to the cost-effectiveness of screening for prostate and breast cancer and how interventions in person-centred and integrated care pathways influence resource use.

    My research on PROMs have generated results regarding how PROMs are used within the Swedish national quality registries (NQRs), the validity of PROMs in different patient groups, and how PROMs from the NQRs can be used to inform decision-making. Currently, I am working on studies of the validity of the HRQoL measure EQ-5D in patient populations with rheumathic disease. 

Articles

All other publications

Grants

  • Swedish Research Council
    1 December 2024 - 30 November 2028
    Sweden has numerous linkable registers which are a goldmine for research in the medical and social sciences. However, as increasingly more complex research questions are being addressed, there are challenges to correctly and efficiently analyse such data, and further methods development is needed. We aim to develop and apply methods for register-based research that are relevant for a wide range of settings. We also aim to transfer new methodology to subject-matter scientists and train the next generation of biostatistical scientists. The long-term goal is to leverage the rich information within the registers for the benefit of patients, policy-makers and society. Specifically, we will develop, evaluate and apply methods for:1. Missing data in registers2. Causal mediation analysis3. Policy-relevant complex disease models and lifetime outcomes in health economics 4. Federated analyses and synthetic data to share information.Our proposal focuses on the development of statistical methods, but each aim is motivated by real problems in medicine and social science, e.g. improving cancer screening, understanding causal mechanisms for social inequalities in cancer survival, time trends in disease incidence trends and situations when individual-level data cannot cross borders. Our team of biostatistical scientists will work in close collaboration with an extended network of Swedish and Nordic register holders, epidemiologists, clinical and social scientists, and relevant stakeholders.
  • Swedish Research Council
    1 January 2023 - 31 December 2025
    Our general aim is to use modelling to reduce the burden due to prostate and cervical cancer through cost-effective screening. For prostate cancer, new tests, magnetic resonance imaging (MRI) and artificial intelligence (AI) assisted pathology are expected to reduce harms while maintaining the mortality benefits from early detection. For cervical cancer, human papillomavirus (HPV) vaccinations are expected to substantially reduce HPV incidence and eventually lead to the eradication of cervical cancer. With changes to HPV transmission, cervical cancer screening may require extended genotyping, self-sampling and renewed guidelines to be cost-effective.We will evaluate the cost-effectiveness of: (i) organised prostate cancer testing (OPT) in Sweden, including MRI and the Stockholm3 test
    (ii) prostate cancer testing using a genetic risk score
    (iii) prostate cancer diagnostics using AI-assisted pathology
    and (iv) primary HPV testing with extended genotyping in vaccinated cohorts with clinic-based testing or self-sampling. These results will inform policy for (a) the development and planning of a national OPT program, (b) the use of AI-assisted histopathology, and (c) the development of national cervical cancer screening guidelines for vaccinated cohorts.
  • Swedish Research Council
    1 January 2019 - 31 December 2022
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2016 - 31 December 2018

Employments

  • Adjunct Lecturer, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, 2023-2025

Degrees and Education

  • Docent, Karolinska Institutet, 2023

News from KI

Events from KI